The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome

Sahin Y., Unluhizarci K., Yılmazsoy A., Yıkılmaz A., Aygen E., Kelestimur F.

CLINICAL ENDOCRINOLOGY, cilt.67, sa.6, ss.904-908, 2007 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 67 Sayı: 6
  • Basım Tarihi: 2007
  • Doi Numarası: 10.1111/j.1365-2265.2007.02985.x
  • Dergi Adı: CLINICAL ENDOCRINOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.904-908
  • Erciyes Üniversitesi Adresli: Evet

Özet

Objective There are conflicting data regarding the effects of metformin in lean women with polycystic ovary syndrome (PCOS). Thus, our aim was to evaluate the effects of 6 months of metformin therapy on various metabolic and cardiovascular risk factors in lean women with PCOS.